Hepatitis C Home > Treatment for Hepatitis C

The most common hepatitis C treatment is called combination therapy. Although the term "combination therapy" previously meant the combination of peginterferon and ribavirin, the approval of various other hepatitis C drugs makes the definition somewhat obsolete. Many people are now using the term to include any hepatitis C regimen that involves more than one medication.
 
Peginterferon (Pegasys® or Peg-Intron®) is given by injection once a week. Ribavirin (Copegus®, Rebetol®) is a pill taken twice daily. Hepatitis C protease inhibitors include boceprevir (Victrelis®), telaprevir (Incivek®), and simeprevir (Olysio™), all of which are taken by mouth with food. Sofosbuvir (Sovaldi™) is taken once daily by mouth, with or without food.
 
The protease inhibitors are used in combination with peginterferon and ribavirin for genotype 1 infections. Sofosbuvir is approved for use with ribavirin for genotypes 2 and 3 or with peginterferon and ribavirin for genotypes 1 and 4. 
 
Studies have shown that when taking peginterferon plus ribavirin, between 40 percent and 80 percent of people have a sustained virological response (SVR) to this treatment for hepatitis C. A sustained response means that no hepatitis C virus RNA can be detected in the person's blood six months after finishing the treatment. Adding a protease inhibitor or sofosbuvir can boost the success rate. 
 
A few different factors can affect the success of treating hepatitis C. These factors include:
 
  • The genotype of the hepatitis C virus (i.e., the specific arrangement of genetic material)
  • The amount of virus present in the body
  • How long the person has had the hepatitis C virus (HCV)
  • The amount of damage already done to the liver.
     
(Click Hepatitis C Treatment for more information about the options available for hepatitis C and suggestions for staying healthy during and after treatment.)
 
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics & Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2017 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.